You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The schools will study 14 plants to discover how genes affect their ability to produce compounds that are, or may be, used in drugs.
The purchase comes as part of a £2 million ($3.3 million) award to establish the Cambridge Lipidomics Biomarker Research Initiative.
The investment from new and old investors nearly doubled Metabolon's Series C financing.
The collaboration will combine mass spec-based metabolite profiling expertise at Duke's Sarah W. Stedman Nutrition and Metabolism Center with complementary technologies at Burnham, particularly NMR-based methods.
A new grant program will fund 'omics, imaging, and other studies to develop disease detection and monitoring technologies.
A Cairo-based organization is looking for collaborators for pharmacogenomics, genomics, proteomics, and various disease-related studies.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Merck, Medarex, and UMass' MBL Ink mAb deal; Vandy licenses cancer Rx assay to DiaTech; MolecularMD sub-licenses OHSU CML mutation test to Mayo Clinic, and more …
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
Wired reports that Oxitec has now developed a genetically modified fall armyworm.
A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.
In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.